Upadacitinib

SI-1066

Upadacitinib, >98% (HPLC)

CAS No. : [1310726-60-3]

MDL No. : MFCD30502663

Synonyms : ABT-494

IUPAC Name : (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	75.00		In Stock	Estimated to ship on 20 September 2026
10MG	125.00		In Stock	Estimated to ship on 20 September 2026
25MG	255.00		In Stock	Estimated to ship on 20 September 2026
50MG	455.00		In Stock	Estimated to ship on 20 September 2026
100MG	855.00		In Stock	Estimated to ship on 20 September 2026
250MG	1655.00		In Stock	Estimated to ship on 20 September 2026
500MG	2655.00		In Stock	Estimated to ship on 20 September 2026

Applications : Upadacitinib (ABT-494) is a potent and selective Janus kinase (JAK) 1 inhibitor with an IC₅₀ of 43 nM, being developed for the treatment of several autoimmune disorders.

References : Genovese M. C. et al.: Arthritis Rheumatol., 68(12), 2857-2866, 2016; Kremer J. M. et al.: Arthritis Rheumatol., 68(12), 2867-2877, 2016; Mohamed M. F. et al.: Clin Pharmacokinet., 55(12), 1547-1558, 2016.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.